Objective: The goal of this study was to develop a reliable and valid method for assessing the cancer-related beliefs of parents with a child in treatment for cancer.
Method: One hundred twenty-five families (119 mothers, 56 fathers) completed a measure of cancer-related beliefs written to reflect common themes associated with the diagnosis and treatment of childhood cancer. Participants also completed self-report questionnaires used for validation of the Family Illness Beliefs Inventory (FIBI).
Results: Principal-components analysis was used to derive a 41-item five-factor solution from the maternal data--Factor 1: Treatment-Related Suffering; Factor 2: Death and Devastation; Factor 3: Caregiver Competence; Factor 4: Connection; and Factor 5: Finding Meaning. Correlations with validation measures supported the factor structure. Paternal data showed similar patterns.
Conclusions: The FIBI is a psychometrically sound method for identifying parental cancer-related beliefs. This measure may be helpful in developing and evaluating interventions to reduce parental distress related to childhood cancer and promote adaptive family functioning.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jpepsy/jsh055 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The role of intolerance of uncertainty in health anxiety in cancer patients: Exploring demographic and cancer-related variations.
Eur J Oncol Nurs
January 2025
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Purpose: Health anxiety (HA) is a critical issue for cancer patients. This study investigates the role of intolerance of uncertainty (IU) in HA among a heterogeneous sample of cancer patients, comparing those with hematological malignancies and solid tumor cancers. It also explores the impact of demographic and cancer-related factors on HA.
View Article and Find Full Text PDFImpact of patient resourcefulness on cancer patients' pain management and medical opioid use: A cross-sectional study.
Eur J Oncol Nurs
December 2024
College of Medicine, Department of Nursing, Chung Shan Medical University. Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road., Taichung, 40201.Taiwan. Electronic address:
Purpose: Negative beliefs about cancer pain and morphine are detrimental to pain interpretation. Patients with high resourcefulness often proactively address problems to cope with stress, and establish problem-solving strategies.The aim of the project is to investigate the impact of resourcefulness and pain interpretation on cancer-related pain control.
View Article and Find Full Text PDFChanges in Skin Cancer-Related Behaviors, Distress, and Beliefs in Response to Receipt of Low- to Moderate-Penetrance Genetic Test Results for Skin Cancer Risk.
Cancers (Basel)
November 2024
Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33162, USA.
Little is known about the impact of low- to moderate-penetrance genetic testing for skin cancer, which is a promising approach to skin cancer prevention. To address this deficit, we conducted an analysis comparing changes in skin cancer-related behaviors, distress, and beliefs measured at a baseline and twice after the receipt of skin cancer precision prevention materials containing risk feedback (higher or average risk) among 568 non-Hispanic White (NHW) and 463 Hispanic participants. Regression analyses identified decreased average weekend hours in the sun (β = -0.
View Article and Find Full Text PDFSleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema.
Sleep Breath
December 2024
Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Article Synopsis
- The study investigates the relationship between breast cancer-related lymphedema (BCRL) and sleep disturbances, particularly obstructive sleep apnea (OSA), among breast cancer survivors (BCSs).
- Using several questionnaires, the quality of sleep and OSA risk were assessed among 71 women with BCRL and 84 without it, revealing that both groups experience high levels of sleep disturbances.
- Results indicated that those with advanced BCRL stages had a higher risk for OSA, with significant correlations between BCRL stage and neck circumference, emphasizing the need for clinical monitoring of sleep issues in this population.
Osimertinib for Uncommon Endothelial Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: A Case Report.
Case Rep Oncol
November 2024
Division of Hematology and Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Article Synopsis
- Non-small cell lung cancer (NSCLC) is the most common lung cancer type, responsible for a majority of cancer deaths globally, and advancements in treatments, especially targeted therapies like osimertinib, have improved management options.
- Osimertinib, a third-generation tyrosine kinase inhibitor, effectively targets specific mutations in the EGFR gene, including rare mutations, as exemplified by a 64-year-old woman whose unique exon 19 mutation responded well to the drug, leading to 26 months of disease control.
- The study highlights the limited research available for rare EGFR mutations and emphasizes the need for further prospective studies to better understand treatment responses and ensure safe and effective therapies for this patient group.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!